
Ozempic users say weightloss drugs are now chic — not shameful: ‘It makes me feel more established because I'm doing the same thing as celebrities'
If friends asked her explicitly if she was using a GLP-1 medication to shed pounds, she would be honest — but she often felt judged. Some pals made comments about how they could never give themselves a shot or asked if it was just another dangerous diet fad.
'It was like speed, no one thought this was a good solution,' said Svensson, who lives in Park Ridge, New Jersey.
9 Caley Svensson has lost nearly 100 pound on weight-loss medication.
Tamara Beckwith
9 She initially kept quiet about going on Mounjaro and faced judgement from friends. Now, she said, it seems like everyone's on the drugs.
Tamara Beckwith
Now, Svensson said, it seems like nearly everyone has gotten off their high horse — often to get on the medications themselves.
Like being in therapy, taking antidepressants or getting Botox, using weight-loss medications such as Ozempic and Mounjaro has gone from being a secretive and sometimes shameful practice to being considered chic. In certain circles everyone seems to be on them — so much so that it's almost a badge of honor.
'All the friends who judged me for it, half of them are on it now,' said Svensson, who has lost over 90 pounds. 'The dirty little secrets people used to have to stay thin, rich, and healthy, they are now out in the open.'
9 Here, Svensson is pictured before she went on the medication.
Courtesy of Caley Svensson
Morgan Stanley Research estimates that 24 million people in the US — roughly 7% of the population — will be taking these drugs by 2035.
Tyler McLoughlin, 32, who lives in Brooklyn and works as an associate director for student life at CUNY, likes the famous and fabulous connotations around the medications.
'All the Real Housewives are taking it, all the celebrities are taking it,' said McLoughlin, who has been on a semaglutide — the class of GLP-1s that include Ozempic and Wegovy — since October. 'It kind of makes me feel more established because I'm doing the same thing as celebrities are doing.'
He is also ecstatic about his new body. His 5-foot-7 frame has gone from 185 to 150 pounds.
9 Archana Pinnapureddy loves telling people about her success with tirzepatide.
Tamara Beckwith
'I was just in Miami this past weekend, and this is the first time in my whole life I felt comfortable wearing a Speedo,' he said. 'I just feel so excited and so proud.'
Archana Pinnapureddy, a 43-year-old tech entrepreneur, isn't just open about the fact that she's been taking tirzepatide, a drug whose brand names include Mounjaro and Zepbound, for the past year, she openly promotes the fact.
She posts about it on her social media channels and tells everyone she meets how great the medication has been for her.
'I am very happy with it. It has given me this new power, that I can be my best self. I can even fit into my college clothes again,' she said. 'You also save money on food and alcohol because you aren't eating and drinking as much when you go out.'
9 Archana (right) and her twin sister Kanchana have both had success slimming down with the drug.
Courtesy of Archana and Kanchana Pinnapureddy
9 Here, the two are pictured before going on the medication.
Courtesy of Archana and Kanchana Pinnapureddy
Pinnapureddy, who is 5-foot-1, has gone from 142 pound to 106 pounds. Her twin sister has had similar results.
'[We] joke that we are walking ads for this medication,' she enthused. 'I've encouraged so many people to get on it. Some people I referred it to dropped 15 pounds in a month.'
Nicholas Salza, 31 and a 911 dispatcher in Fairfield, CT, has been on tirzepatide since August 2024 and lost 125 pounds. He doesn't understand why anyone would hide or feel shame about something that can be such a boost to health.
'Why wouldn't you do something to help yourself, especially after failing in so many diets and workouts or committing to the gym for a couple of weeks and not sticking to it?' he said. 'When something works, why wouldn't you spread awareness to people who may be going through the same thing?'
9 Nicholas Salza weighed 425 pounds before (left) going on Tirzepatide. He now (right) weighs about 300 pounds.
9 'Why wouldn't you do something to help yourself, especially after failing in so many diets and workouts or committing to the gym for a couple of weeks and not sticking to it?' said Salza (pictured before his weight-loss).
Courtesy of Nicholas Salza
9 'When something works, why wouldn't you spread awareness to people who may be going through the same thing?' said Salza (pictured after he slimmed down).
Courtesy of Nicholas Salza
Pinnapureddy notes that even if she wanted to keep mum about being on a GLP-1, it would be a challenge.
'I feel like it's kind of obvious that you're on them if you were never skinny and all of a sudden boom, you're thin,' she said. 'It's rare that you can do that especially if you're in your late '30s and '40s.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
37 minutes ago
- Yahoo
Ozempic-Like Drugs Could Treat Chronic Migraines, Trial Finds
Medications sold under brand names like Ozempic, Wegovy, and Saxenda have become famous for their weight-loss benefits, but that only scratches the surface of what these injections are potentially capable of. Originally designed to treat type 2 diabetes, GLP-1 agonists have also shown unforeseen benefits to heart, brain, liver, and kidney health – and now, it seems, the head, alleviating migraines in a new study. In a pilot trial of 31 patients with high BMI and frequent or chronic migraines, participants who received a daily injection of the GLP-1 agonist liraglutide experienced significantly fewer painful headaches. After 12 weeks, the number of days with a migraine each month decreased from a mean of 19.8 days to just 10.7 days – a reduction of nearly half. Related: Weight loss, age, sex, and the use of other medications at the same time did not significantly alter the results. "Our findings show that liraglutide may be effective in the treatment of unresponsive high-frequency or chronic migraine in patients with obesity, and that this effect is independent from weight loss," conclude the authors, who hail from the University of Naples in Italy. "This suggests… that the mechanisms driving liraglutide's effectiveness in migraine prevention may operate independently of the significant metabolic effects… " Further studies with larger cohorts and a control group are needed to verify that hypothesis. But GLP-1 agonists, like liraglutide and possibly even its longer-lasting relative semaglutide, may prove to be a promising route for future migraine treatments. Migraines impact an estimated 14 to 15 percent of the global population, and yet the few medications we have on hand do not work for everybody. "A substantial number of patients still face an unmet need, especially when preventive drugs prove ineffective," writes a team of scientists led by neurologist Simone Braca. Participants in the current pilot trial had migraines unresponsive to other treatments, meaning liraglutide worked where other drugs had not. GLP-1 agonists slow appetite and help regulate blood sugar by mimicking a natural hormone in the body, called glucagon-like peptide-1, which is released after eating. That's why these drugs are so effective when it comes to managing type 2 diabetes and weight gain. But GLP-1 receptors exist throughout the body, in many different tissues and organs. The fact that liraglutide and similar medications have widespread effects outside of the pancreas makes logical sense. Still, scientists are trying to figure out what those effects are, and whether they help or harm. In recent years, studies have shown liraglutide and other GLP-1 agonists can greatly reduce intracranial pressure in the brain – a speculative trigger for migraines. In animal models, these drugs have also suppressed migraines with great effectiveness. The current pilot trial is only small and it did not investigate the mechanisms behind liraglutide's migraine relief, nor did it directly measure intracranial pressure among participants. Nevertheless, Braca and her colleagues suspect that reduced pressure in the skull is playing a role in migraine reduction. In recent animal studies, GLP-1 agonists reduced fluid in the central nervous system, thereby lowering intracranial pressure. "These findings provide a foundation for larger-scale trials aimed at further investigating the role of GLP-1R agonists in migraine management," Braca and her team conclude. The study was published in Headache. Gut Bacteria Found to Soak Up Toxic Forever Chemicals Gene Therapy Can Restore Hearing in Adults, First-of-Its-Kind Trial Shows Cheese May Actually Fuel Nightmares, Surprising Study Confirms
Yahoo
12 hours ago
- Yahoo
I went on my first diet age 10. Now I'm on Mounjaro and won't look back
I was just 10 years old when I went on my first diet. I remember so vividly being little and first becoming aware of my body, that it was different from everyone else's, or that I was built differently to my friends. My mum and I would even have contests to see who could lose the most weight. Ever since then I struggled endlessly with my weight – until I came to the decision stay on the weight-loss drug Mounjaro for the rest of my life. The truth is, I've tried everything – Weight Watchers, SlimFast, the Atkins Diet. I even tried cutting out refined foods and dairy, and drinking solely shakes. I hired a personal chef, and a personal trainer too. Nothing stuck. Then I went on Mounjaro and lost 2st in three months, and 6st within a year. Now that I've reached 10st, my focus is on maintaining it. That is why I am still on the medication and will probably be on it forever. I have to keep the obesity at bay, and Mounjaro treats my disease and keeps me healthy. I know a lot of people will have their opinions of me and my choices – I've heard it all. I'm ok with what they say because amongst all the hate, maybe I've reached someone who might be afraid of trying it, and this story changes their life. My husband Erik and I live with our three children, two daughters aged eight and five, and one son aged 11, in New Jersey. I was a teacher for 10 years but after I had my first child in 2014, I switched jobs to be able to work from home because it was difficult to pay for daycare. After my second child, my husband became a full-time doctor and made enough money so that I was able to become a stay-at-home mum. For the next eight years, I continued as normal while eating huge food portions. Eventually, it got out of control. I couldn't breathe doing cardio, I couldn't even play with my children. I'm an avid equestrian and I wasn't able to ride or do my lessons any more. We'd just trot around – I felt so bad that I was letting my horse down. I can't even tell you how many weddings I turned down because I wasn't happy with my weight, or how many social events I missed because I didn't feel pretty enough. I felt I was the only person in the world struggling. My mum and my grandmother both suffer from obesity as well. Growing up, my mum would say, 'Oh, we don't eat that food', or 'That's bad food, we need to eat good food.' Her words contributed to an unhealthy narrative around food. I always felt bad about eating a cookie or a slice of cake. It wasn't healthy to be having these conversations about my body at such a young age. During my 20s and 30s, I thought that my health was infallible and that nothing could happen to me. Then in 2022, when I was 16st and just about to turn 40, I got my blood tests back and I discovered I was pre-diabetic and obese. It was such a shock to me: I'd always know I was a bit bigger, but I didn't realise my health was reflecting that. I was at the end of my tether – something had to change. I read an article in The New York Post about someone else's experience on this medication first came out it was still new in treating weight loss. Before Mounjaro, weight-loss drugs had a very bad reputation – they had terrible side effects so you couldn't be on them for too long. I sat my husband down and told him I'd looked into this new drug and I wanted to explore it. He said he wanted me to do some research into it to make sure it wasn't just a fad, but after a few days he came back to me and said that it was a legitimate medication. We then went about finding a doctor. At the time, only endocrinologists were prescribing the medication because of their work with diabetic patients, and because I was pre-diabetic, I was able to qualify, so we travelled to New York City. My endocrinologist prescribed me the starting dose, 2.5mg. She prepared me well for the side effects. She said I'd feel nauseous for the first couple of months, I might feel tired, and I wouldn't feel hungry. I'd describe the side effects to be similar to the first trimester of pregnancy. I know a lot of women on the medication suffer from constipation or diarrhoea but fortunately, I didn't have that. The doctor recommended I work with a nutritionist during the first months. I realised that although I was not hungry, I still had to fuel my body with good food. The nutritionist told me that not eating balanced meals while on the medication could lead to hair loss, skin issues and a vitamin D deficiency. She told me to take a fibre supplement, drink plenty of water and drink protein shakes or smoothies daily. Three years later, a protein shake is still my go-to life hack – it's like a cheat sheet to ensure you are getting the nutrients in. When I first started using Mounjaro, I was very quiet about it. My husband was the only person that knew about it for three months. I was nervous about the judgement – what if people told me that I took the easy way out? I lost 30lb (2st) in three months, and slowly friends would start to tell me that I looked good, and I decided to be honest about how I'd done it. My relationship with food also changed: I had so much emotional baggage and lifelong disappointment that I had to learn to erase. I had to learn that there was no such thing as 'bad food', it was just food. If I wanted to have some chocolate cake, I could have a few bites and have the strength to walk away. On previous diets, if I ate a slice of chocolate cake, I'd spiral and binge-eat the entire cake. After a few months on 2.5mg, I went up to 5mg for three months. After that I stopped losing weight, so I increased it to 7.5mg. Every time I plateaued and went longer than three weeks without weight loss, I would increase the dose. Once I went up to 12.5mg I reached my target of losing 95lb, which is just over 6st. The medication has offered me so many other health benefits – the inflammation in my knees and ankles has gone down. Before I lost weight, I was having a lot of trouble on my horse and I went to physical therapy to try and address it, but nothing worked. Once I lost the weight, I suddenly didn't have any pain at all. My anxiety and depression have also drastically improved. When I weighed 16st, I was unable to leave my house and when I did, it was only to go into town to run errands. If anyone asked me to go for lunch or dinner, the answer was no. If I was invited to a party for the evening, I wouldn't go. After losing 6st, the travel fear went away – me and my husband went on a flight to Paris, and took weekend trips to New York City. When I started noticing results, I decided to make a TikTok account because at the time, none of my friends were on there, so I could post without them seeing. Eleven months into using Mounjaro, I'd slimmed down to a US size 6 (roughly a UK size 10). I fit into clothes that I couldn't fit into before; going in and being able to fit into medium and small-sized clothes was so exciting. I was able to go out to parties and I became very social. I gained a newfound confidence which many people start to lose in their 40s but for me, it continues to grow. I've started dabbling in interior design and am even considering opening up my own business. I just know I wouldn't have had the confidence to do that three years ago. Ironically, I feel like my mum was a bit jealous of my successful weight loss. She realised how hard she had to work and how much she had to restrict herself to stay in shape, whereas I was able to be healthier and thinner without all that hard work. At dinner, I was able to order pasta and a glass of wine, and she had to sit there with her plain chicken. I had a lot more enjoyment in my life and I think she was envious of how many people said I looked good. After I had lost around 75lb, Erik took me to a shop so I could buy new boots and breeches. It was so exciting to be able to buy equestrian clothes that I wasn't able to fit into before. I love the European equestrian brands like Redpost and Holland Cooper, and now I could shop there – these are the experiences that I hold so dear. I suffer from chronic depression, and although Mounjaro has helped me manage some of my symptoms, I know I'll be on antidepressants for the rest of my life. I truly believe it's the same with obesity, and so my clinician and I worked to bring me down to a dose that keeps me balanced, so I'm not losing or gaining weight. We initially trialled going from 12.5mg down to 7.5mg, but I started to gain weight again so I went back up to 10mg and have stayed there for almost two years. I've had such a good experience with the medication that my husband started to take it too. He isn't obese, but once he hit 40, he became more conscious of his dad bod and wanted to feel good about himself. He hasn't lost as much as I did, probably around 30 to 40lb, and I think that is down to the fact he's not clinically obese. We are still figuring things out and discovering new science with this medication – we are the first generation. Now I look at my eight-year-old daughter, who is a fuller-sized, beautiful girl, and know that's ok. We have healthy conversations about listening to our bellies and eating when we are hungry. I don't want her on Mounjaro, but if she needed to be on it when she's older, I'd understand. Some parts of maintaining her figure are out of her control, and now there's medication to help with that. That's why I look at Mounjaro as the medication that broke my generational curse. My only issue is with how cost-prohibitive the medication is. In the US, most of the insurance companies don't cover weight-loss drugs, even though obesity is a disease. They believe that everyone can just lose weight with diet and exercise, when that is not the case. I pay $1200 (£880) a month for my medication – that's most people's rent, a lot can't afford it. (In the UK, you can get Mounjaro on an NHS prescription for £9.90, or from a private clinic for around £180 a month.) I'm so happy that there's finally an answer to obesity. At 41, the unhealthy food narratives that have always been a battle, I've finally been able to put to an end. As told to Nicole Collins Breakfast: Coffee, three eggs, two pieces of toast Snack: Handfuls of cereal, children's snacks Lunch: A foot-long Subway sandwich with crisps, a cookie and a soda More snacking Dinner: Large portion of chicken and pasta Dessert: Coco puffs Alcohol: Two glasses of wine at night Exercise: Horse riding – even though it was very difficult Breakfast: High-fibre cereal like raisin bran Snack: Protein shake Lunch: Soup and Vietnamese spring roll Dinner: Light dinner like a mince salad with taco shells Dessert: No dessert Alcohol: Mounjaro changed my relationship with alcohol, so I don't drink any more unless I'm out in a social setting, and I often feel nauseous when I do Exercise: Horse riding, I'm now able to ride properly every day By Dr Kaywaan Khan, a GP and weight-loss and wellbeing specialist at Hannah London, and Dr Leah Totton, a medical and cosmetic doctor at Dr Leah Clinics and Skincare Yes, you can use Mounjaro in the long term, says Dr Khan. Some people 'will take the medication forever because they not only have obesity as a chronic disease, but they [have conditions such as] heart disease or diabetes so taking this medication is part of their core health treatment and preventative health care,' Dr Khan adds. 'A woman who is already overweight might already be having irregular periods, so Mounjaro might actually help those women to regulate their periods,' says Dr Khan. 'It can potentially stop periods if you have too little fat. Alternatively you might have enough fat but if you lose weight too quickly, it can put the body into shock because of a very little calorie intake.' 'Slow weight loss is advised. I would recommend reducing the speed in which you lose weight and increasing your protein intake during the weight loss process,' says Dr Totton. 'I would also suggest doing resistance training to work on the lean muscle mass. You can also take collagen peptides and vitamin C to support skin health, or consider treatments such as radio frequency or microneedling to stimulate collagen elastin and tighten the skin.' Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.


Business Upturn
13 hours ago
- Business Upturn
Shilpa Medicare subsidiary clears GMP inspection from ANVISA with no major observations
By Aman Shukla Published on July 4, 2025, 16:10 IST Shilpa Medicare Limited announced that its wholly owned subsidiary, Shilpa Pharma Lifesciences Limited (Unit-1), has successfully completed a Good Manufacturing Practice (GMP) inspection conducted by the Brazilian regulatory authority, ANVISA. In the exchange filing, the company shared, 'This is to inform you that the Shilpa Medicare Limited's 100% subsidiary, Shilpa Pharma Lifesciences Limited, Unit-1 has successfully completed GMP inspection from Brazilian regulatory authority, ANVISA. ' The inspection took place from June 30 to July 4, 2025, and concluded with no critical or major observations—a key milestone for the company's global regulatory compliance. Only minor procedural observations and recommendations were noted, which were discussed during the course of the audit. Shilpa Medicare stated that it remains committed to maintaining the highest quality and regulatory standards. The company will submit a Corrective and Preventive Action (CAPA) plan to address the minor points raised, within the stipulated timelines set by the agency. This successful outcome reinforces Shilpa's position in regulated markets and supports its ongoing efforts to expand its international presence, particularly in Latin America. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at